FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1115011000001100: Carbamazepine 200mg tablets 500 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21957701000001119 Carbamazepine 200mg tablets 500 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21957801000001111 Carbamazepine 200mg tablets 500 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbamazepine 200mg tablets 500 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets 500 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets 500 tablet Is pack of Product containing precisely carbamazepine 200 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets 500 tablet Has active ingredient Carbazepine antiepileptic false Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets 500 tablet Has active ingredient Carbamazepine false Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets 500 tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets 500 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets 500 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets 500 tablet Has VMP Product containing precisely carbamazepine 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets 500 tablet Has specific active ingredient Carbamazepine true Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets 500 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets 500 tablet VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets 500 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Carbamazepine 200mg tablets (A A H Pharmaceuticals Ltd) 500 tablet Is a True Carbamazepine 200mg tablets 500 tablet Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets (Viatris UK Healthcare Ltd) 500 tablet Is a True Carbamazepine 200mg tablets 500 tablet Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets (Kent Pharma (UK) Ltd) 500 tablet Is a True Carbamazepine 200mg tablets 500 tablet Inferred relationship Existential restriction modifier
Carbamazepine 200mg tablets (Unichem Plc) 500 tablet Is a True Carbamazepine 200mg tablets 500 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start